期刊文献+

Fractalkine对类风湿关节炎成纤维样滑膜细胞增殖的影响 被引量:2

The role of fractalkine in the proliferation of fibroblast-like synoviocytes obtained from rheumatoid arthritis
下载PDF
导出
摘要 目的明确fractalkine(CX3CL1)对人类风湿关节炎成纤维样滑膜细胞(RA-FLS)增殖的影响。方法通过组织块法培养RA-FLS。分别用0、50、100ng/mL重组人fractalkine刺激RA-FLS24h,用四唑盐(MTT)法检测其吸光度值,比较各组间增殖率。结果 50ng/ml及100ng/ml fractalkine均可促进RA-FLS增殖(P=0.005,P=0.022)。结论 Fractalkine可促进RA-FLS的增殖,可部分解释RA-FLS自主增殖的特性。 Objective To observe the effect of fractalkine(CX3CL1) on the proliferation of fibroblast-like synoviocytes(FLS) obtained from rheumatoid arthritis(RA).Methods RA-FLS were gained through tissue culture.Use fractalkine to stimulate RA-FLS in concentration of 0,50,100 ng/mL for 24 h,test the absorbance by the MTT cell proliferation assay,and compare the growth rate among each group.Result Fractalkine stimulates cell growth in RA-FLS at concentration of 50 or 100 ng/mL(P=0.005,P=0.022).Conclusion Fractalkine can promote the proliferation of RA-FLS,and it partly explains the characteristic of self duplication in RA-FLS.
出处 《解剖学研究》 CAS 2010年第5期361-364,共4页 Anatomy Research
基金 广东省自然科学基金项目(9151202602000004)
关键词 CX3CL1 类风湿关节炎 成纤维样滑膜细胞 细胞增殖 CX3CL1 Rheumatoid arthritis Synovial fibroblast Proliferation
  • 相关文献

参考文献11

  • 1EdwardD.凯利风湿病学.7版.北京:人民卫生出版社,2006:869-873.
  • 2Volin MV,uynh N,losowska K,t al.Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt.Arthritis Rheum,2007,56(8):2512-22.
  • 3Bachstetter AD,organti JM,ernberg J,t al.Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats.Neurobiol Aging,2009,15.[Epub ahead of print].
  • 4Lyons A,ynch AM,owner EJ,t al.Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro.J Neurochem,2009,110(5):1547-56.
  • 5Chandrasekar B,ummidi S,erla RP,t al.Fractalkine (CX3CL1) stimulated by nuclear factor κB(NF-κB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.Biochem J,2003,373(2):547-558.
  • 6Lee YR,ee JH,oh EM,t al.Guggulsterone blocks IL-1b-mediated inflammatory responses by suppressing NF-jB activation in fibroblast-like synoviocytes,ife Sci.2008,82:1203-1209.
  • 7Tolboom TC,ieterman E,an der laan WH,t al.Invasive properties of fibroblast of MMP-1,MP-3,nd MMP-10.Ann Rheum Dis,2002,61(11):975-980.
  • 8Muller-Ladner U,riegsmann J,ranklin BN,t al.Synobial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.Am J Pathol,1996,149(5):1607-1615.
  • 9Yoshikawa M,akajima T,atsumoto K,t al.TNF-α and IL-4 regulate expression of fractalkine (CX3CL1) as a membrane-anchored proadhesive protein and soluble chemotactic peptide on human fibroblasts.FEBS Lett,2004,561:105-110.
  • 10Fraticelli P,ironi M,ianchi G,t al.Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.J Clin Invest,2001,107:1173-1181.

同被引文献20

  • 1蔡蓓,王兰兰,冯伟华,陈捷,唐江涛,武永康.共刺激信号分子表达异常与自身免疫性疾病的关系[J].免疫学杂志,2006,22(1):65-67. 被引量:9
  • 2Amett FC,Edworthy SM,Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis and Rheumatism,1988.315-324.
  • 3Van Gestel AM,Haaqsma CJ,van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts[J].Arthritis and Rheumatism,1998.1845-1850.
  • 4Felson DT,Anderson JJ,Boers M. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis[J].Arthritis and Rheumatism,1995.727-735.
  • 5Bronner MC,Hoff H,Burmester GR. Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses:implications for arthritis and autoimmune diseases[J].Arthritis Research & Therapy,2004.45-54.
  • 6Lu MF,Yang CY,Li JS. Increased expression of downregulatory CTLA-4 molecule on T lymphocytes from rheumatoid synovial compartment[J].Scandinavian Journal of Immunology,1999.68-72.
  • 7Genovese MC,Becker JC,Schiff M. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor inhibition[J].New England Journal of Medicine,2005.1114-1123.
  • 8Kremer JM,Dougados M,Emery P. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept:twelve-month results of a phase iib,double-blind,randomized,placebo-controlled trial[J].Arthritis and Rheumatism,2005.2263-2271.
  • 9Kooloos WM,de Jong DJ,Huizinga TWJ. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease[J].Drug Discovery Today,2007.125-131.
  • 10Matsunawa M,Isozaki T,Odai T. Increased serum levels of soluble fractalkine(CX3CLI)correlate with disease activity in rheumatoid vasculitis[J].Arthritis and Rheumatism,2006.3408-3416.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部